Clinical trial
Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea
NCT01181570 is registered in ClinicalTrials.gov with Innovaderm Research Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea
- Lead sponsor
- Innovaderm Research Inc.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2010
- Completion date
- September 30, 2011
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.